Literature DB >> 10885762

Latency and reservoirs for HIV-1.

R F Siliciano1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10885762

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  10 in total

1.  An anti-CD45RO immunotoxin kills HIV-latently infected cells from individuals on HAART with little effect on CD8 memory.

Authors:  J Saavedra-Lozano; Y Cao; J Callison; R Sarode; D Sodora; J Edgar; J Hatfield; L Picker; D Peterson; O Ramilo; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

2.  Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity.

Authors:  P R Gorry; G Bristol; J A Zack; K Ritola; R Swanstrom; C J Birch; J E Bell; N Bannert; K Crawford; H Wang; D Schols; E De Clercq; K Kunstman; S M Wolinsky; D Gabuzda
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

3.  Antiretroviral Drug-Resistance Mutations on the Gag Gene: Mutation Dynamics during Analytic Treatment Interruption among Individuals Experiencing Virologic Failure.

Authors:  James R Hunter; Domingos E Matos Dos Santos; Patricia Munerato; Luiz Mario Janini; Adauto Castelo; Maria Cecilia Sucupira; Hong-Ha M Truong; Ricardo Sobhie Diaz
Journal:  Pathogens       Date:  2022-05-03

4.  A single amino acid change and truncated TM are sufficient for simian immunodeficiency virus to enter cells using CCR5 in a CD4-independent pathway.

Authors:  A Bonavia; B T Bullock; K M Gisselman; B J Margulies; J E Clements
Journal:  Virology       Date:  2005-10-10       Impact factor: 3.616

5.  Characterization of the follicular dendritic cell reservoir of human immunodeficiency virus type 1.

Authors:  Brandon F Keele; Loubna Tazi; Suzanne Gartner; Yiling Liu; Trever B Burgon; Jacob D Estes; Tyler C Thacker; Keith A Crandall; Justin C McArthur; Gregory F Burton
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

6.  Zidovudine, lamivudine, and abacavir have different effects on resting cells infected with human immunodeficiency virus in vitro.

Authors:  Jesús Saavedra-Lozano; Cynthia C McCoig; Yanying Cao; Ellen S Vitetta; Octavio Ramilo
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

7.  Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain.

Authors:  Lachlan Gray; Michael Roche; Melissa J Churchill; Jasminka Sterjovski; Anne Ellett; Pantelis Poumbourios; Shameem Sherieff; Shameem Sheffief; Bin Wang; Nitin Saksena; Damian F J Purcell; Steven Wesselingh; Anthony L Cunningham; Bruce J Brew; Dana Gabuzda; Paul R Gorry
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

8.  Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors.

Authors:  Marco Sgarbanti; Alessandra Borsetti; Nicola Moscufo; Maria C Bellocchi; Barbara Ridolfi; Filomena Nappi; Giulia Marsili; Giovanna Marziali; Eliana M Coccia; Barbara Ensoli; Angela Battistini
Journal:  J Exp Med       Date:  2002-05-20       Impact factor: 14.307

9.  HIV Infected T Cells Can Proliferate in vivo Without Inducing Expression of the Integrated Provirus.

Authors:  Andrew Musick; Jonathan Spindler; Eli Boritz; Liliana Pérez; Daniel Crespo-Vélez; Sean C Patro; Michele D Sobolewski; Michael J Bale; Carolyn Reid; Brandon F Keele; Adam Capoferri; Wei Shao; Ann Wiegand; Francesco R Simonetti; John W Mellors; Stephen H Hughes; John M Coffin; Frank Maldarelli; Mary F Kearney
Journal:  Front Microbiol       Date:  2019-10-01       Impact factor: 5.640

10.  Global HIV/AIDS Clinical and Translational Pharmacology.

Authors:  Gene D Morse; Gary Maartens; Charles Chiedza Maponga; Qing Ma
Journal:  AIDS Res Treat       Date:  2012-07-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.